Tuning Butyrylcholinesterase Inactivation and Reactivation by Polymer-Based Protein Engineering.
Ontology highlight
ABSTRACT: Organophosphate nerve agents rapidly inhibit cholinesterases thereby destroying the ability to sustain life. Strong nucleophiles, such as oximes, have been used as therapeutic reactivators of cholinesterase-organophosphate complexes, but suffer from short half-lives and limited efficacy across the broad spectrum of organophosphate nerve agents. Cholinesterases have been used as long-lived therapeutic bioscavengers for unreacted organophosphates with limited success because they react with organophosphate nerve agents with one-to-one stoichiometries. The chemical power of nucleophilic reactivators is coupled to long-lived bioscavengers by designing and synthesizing cholinesterase-polymer-oxime conjugates using atom transfer radical polymerization and azide-alkyne "click" chemistry. Detailed
SUBMITTER: Zhang L
PROVIDER: S-EPMC6947490 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA